title: P2 receptor expression profiles in human vascular smooth muscle and endothelial cells.
abstract: P2 receptors mediate the actions of the extracellular nucleotides ATP, ADP, UTP, and UDP, regulating several physiologic responses including cardiac function, vascular tone, smooth muscle cell (SMC) proliferation, platelet aggregation, and the release of endothelial factors. P2 receptor characterization has been hampered by the lack of selective antagonists. The aim of the current study was to investigate the mRNA and protein expression of P2X and P2Y receptors in human SMC and in endothelial cells (EC). Smooth muscle cells were obtained from human mammary artery and EC from human umbilical vein. Using real-time PCR, the authors established quantitative mRNA assays. Protein expression was studied using Western blotting with recently developed antibodies. The P2X1 receptor was highly specific for human SMC, while the P2X4 was the highest expressed receptor in EC. The P2Y2 receptor was present in both SMC and EC. UTP-mediated effects in these cells are likely to be mediated by P2Y2 and not P2Y4 receptors since the latter had considerably lower expression. The P2Y6 receptor was expressed in both SMC and EC. The P2Y1 and surprisingly the P2Y11 receptors were the most abundantly expressed P2Y receptors in the endothelium. Overall, Western blotting confirmed the mRNA findings in most aspects, and most interestingly, indicated oligomerization of the P2Y1 receptor that may be important for its function. In conclusion, P2X1, P2Y2, and P2Y6 are the most expressed P2 receptors in SMC and are thus probably mediating the contractile and mitogenic actions of extracellular nucleotides. The P2X4, P2Y11, P2Y1, and P2Y2 are the most expressed P2 receptors in EC, and are most likely mediating release of nitric oxide, endothelium-dependent hyperpolarizing factor (EDHF), and t-PA induced by extracellular nucleotides. These findings will help to direct future cardiovascular drug development against the large P2 receptor family.
authors.affiliation: Department of Cardiology, Lund University Hospital, Lund, Sweden.
authors.forename: Lingwei
authors.initials: L
authors.lastname: Wang
authors.forename: Lena
authors.initials: L
authors.lastname: Karlsson
authors.forename: Sara
authors.initials: S
authors.lastname: Moses
authors.forename: Anna
authors.initials: A
authors.lastname: Hultgårdh-Nilsson
authors.forename: Maria
authors.initials: M
authors.lastname: Andersson
authors.forename: Catharina
authors.initials: C
authors.lastname: Borna
authors.forename: Tomas
authors.initials: T
authors.lastname: Gudbjartsson
authors.forename: Sverker
authors.initials: S
authors.lastname: Jern
authors.forename: David
authors.initials: D
authors.lastname: Erlinge
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D017931:DNA Primers; D004730:Endothelium, Vascular / Q000502:physiology*; D008323:Mammary Arteries; D009131:Muscle, Smooth, Vascular / Q000276:immunology / Q000502:physiology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D017466:Receptors, Endothelin / Q000502:physiology*; D018048:Receptors, Purinergic P2 / Q000276:immunology / Q000502:physiology*; D014471:Umbilical Veins
chemical_list: D017931:DNA Primers; D012333:RNA, Messenger; D017466:Receptors, Endothelin; D018048:Receptors, Purinergic P2